Results 191 to 200 of about 12,063 (290)

Peri‐Implantitis and Soft Tissue Dehiscence in a Turkish Population: Risk Indicators, Diagnostic Parameters and Biomarkers Discovery

open access: yesJournal of Periodontal Research, EarlyView.
In this Turkish cohort, several risk indicators were identified for peri‐implantitis and peri‐implant soft‐tissue dehiscence. Several PICF immunological markers, particularly IL‐8 and TNF‐α, showed promising diagnostic potential for peri‐implantitis.
Sila Cagri Isler   +5 more
wiley   +1 more source

Membranes for Periodontal and Bone Regeneration: Everything You Need to Know

open access: yesJournal of Periodontal Research, EarlyView.
This paper presents and highlights a summary of the past, present, and future of membranes for oral regeneration in clinical applications and fundamental studies. ABSTRACT Implant dentistry and periodontology have shown an increasing demand for regenerative procedures associated with biomaterials targeting successful clinical outcomes and predictable ...
Marcel F. Kunrath   +5 more
wiley   +1 more source

Cell Therapy for Periodontal, Soft‐Tissue, and Craniofacial Regeneration

open access: yesJournal of Periodontal Research, EarlyView.
The clinical translation of mesenchymal stem/stromal cells (MSCs) represents a major advancement in dentistry, especially for periodontal, soft‐tissue, and craniofacial regeneration. However, several challenges remain to be addressed, including the absence of standardised protocols, limited scalability, regulatory hurdles, a lack of well‐controlled ...
Kamal Mustafa   +5 more
wiley   +1 more source

Efficacy of tunnel technique in the treatment of localized and multiple gingival recessions: A systematic review and meta‐analysis [PDF]

open access: green, 2018
Lorenzo Tavelli   +5 more
openalex   +1 more source

Thirty Years of Autologous Platelet Concentrates: From Platelet‐Rich Plasma to Platelet‐Rich Fibrin

open access: yesJournal of Periodontal Research, EarlyView.
ABSTRACT Nearly three decades have now passed since autologous platelet concentrates (APCs) were introduced into clinical practice. Harnessing the body's innate intrinsic capacity for healing, the concepts of platelet‐rich plasma (PRP) and platelet‐rich fibrin (PRF) emerged to concentrate growth factors and cells at supra‐physiological levels.
Richard J. Miron   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy